Chromadex Corp.
(NASDAQ : CDXC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Process Industries » Chemicals Specialty
symbolcompany%chnglast%shortavg$volume
LINLinde Plc 0.44%234.230.0%$400.50m
APDAir Products & Chemicals, Inc. 0.59%293.961.5%$245.91m
ECLEcolab, Inc. 0.02%204.911.6%$210.07m
DOWDow, Inc. -0.70%48.482.5%$189.98m
LYBLyondellBasell Industries NV -0.26%76.882.8%$150.29m
DQDaqo New Energy Corp. 0.05%198.100.2%$141.28m
AVTRAvantor, Inc. -2.16%24.900.0%$119.85m
ALBAlbemarle Corp. 1.61%96.493.7%$103.82m
REGIRenewable Energy Group, Inc. -4.88%58.8425.1%$71.79m
PEIXPacific Ethanol, Inc. -2.63%8.871.8%$57.58m
LTHMLivent Corp. 1.70%10.780.0%$52.97m
ASHAshland Global Holdings, Inc. 0.73%75.493.3%$31.42m
GRAW.R. Grace & Co. 2.03%48.681.6%$27.85m
GEVOGevo, Inc. -1.84%1.073.4%$24.39m
AVNTAvient Corp. -0.28%32.650.0%$23.66m

Company Profile

Chromadex Corp. is a nutraceutical company. The firm engages in acquiring, developing and commercializing proprietary-based ingredient technologies. It operates through the following segments: Ingredients, Consumer Products, and Analytical Reference Standards and Services. The Ingredients segment offers NIAGEN in an ingredient form to partners. The Consumer Products segment sells TRU NIAGEN to improve health by safely raising NAD levels. The Analytical Reference Standards and Services segment provides product regulatory approval and scientific advisory services to the clients in the food, supplement, and pharmaceutical industries. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in September 1999 and is headquartered in Los Angeles, CA.